Video Description

In this episode of Longevity with David Rubenstein, we explore the cutting-edge neuroscience of aging and Alzheimer’s — from the first subtle signs of memory loss to breakthrough drugs that could slow or even prevent cognitive decline. Rubenstein speaks with leading experts: Dr. Richard Isaacson, Dr. Maria Carrillo, Dr. Vivek Murthy, and Bloomberg’s Robert Langreth to uncover how science, lifestyle and technology are transforming our understanding of brain health. This episode also examines the economic impact of dementia, including the costs to patients, caregivers, and healthcare systems, and how pharmaceutical companies are investing in the next generation of Alzheimer’s treatments. Chapters: 00:00:00 - The Complexity of the Human Brain 00:03:15 - Difference between Alzheimer's and Dementia 00:05:01 - Early Signs of Alzheimer's 00:06:26 - Dr. Alzheimer 00:08:16 - Risks for developing dementia 00:09:04 - What to do to prevent Alzheimer's 00:09:39 - U.S. POINTER Study 00:12:21 - Age and Gender Risk 00:13:00 - The Cost of Dementia in 2025 00:13:59 - Pharmaceuticals investing in Alzheimer treatments 00:14:22 - FDA approved drugs 00:15:02 - Blood tests to detect Alzheimer's 00:19:35 - What can people do today to prevent risk of Alzheimer's 00:20:20 - Brain healthy foods 00:22:53 - No cure for Alzheimer's yet, but can slow it down -------- Like this video? Subscribe to The David Rubenstein Show on YouTube: https://www.youtube.com/channel/UCqsN9MYiu1mKSAsYoF6ppTg Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here: https://www.bloomberg.com/peer-to-peer Learn more about David: http://www.davidrubenstein.com/ Connect with us on... Twitter: https://twitter.com/business Facebook: https://www.facebook.com/bloombergbusiness Instagram: https://www.instagram.com/bloombergbusiness/